SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: steve kammerer who wrote (9987)10/23/2008 11:54:50 AM
From: tom pope1 Recommendation  Read Replies (1) | Respond to of 10345
 
I've always thought, ever since Doomsday, that Elan was not sufficiently aggressive in forcing the PML issue, leaving the lead to BIIB which may have had a bit of a conflict of interest.

Can't now remember exactly when the PML bomb hit, which is sort of surprising. It's not often that I lose $160k over a couple of hours. It should have been seared in my memory.



To: steve kammerer who wrote (9987)10/23/2008 1:21:03 PM
From: scaram(o)uche1 Recommendation  Read Replies (3) | Respond to of 10345
 
Better drugs? I wouldn't give Campath to a sick dog.

(no position in ELN)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News